Pages that link to "Q36809751"
Jump to navigation
Jump to search
The following pages link to Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease (Q36809751):
Displaying 19 items.
- Prospects for gene transfer for clinical heart failure (Q26830145) (← links)
- Covalently linking poly(lactic-co-glycolic acid) nanoparticles to microbubbles before intravenous injection improves their ultrasound-targeted delivery to skeletal muscle (Q30426977) (← links)
- Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease (Q30449821) (← links)
- Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis. (Q30486693) (← links)
- VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial (Q33713721) (← links)
- Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis (Q33765463) (← links)
- HuR: a promising therapeutic target for angiogenesis (Q34070037) (← links)
- Update on gene therapy for myocardial ischaemia and left ventricular systolic dysfunction or heart failure (Q35069886) (← links)
- Emerging role of PKA/eNOS pathway in therapeutic angiogenesis for ischaemic tissue diseases (Q36042713) (← links)
- Biological approaches to ischemic tissue repair: gene- and cell-based strategies (Q37176436) (← links)
- Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets (Q37374651) (← links)
- Prolyl 4-hydroxylases, master regulators of the hypoxia response (Q38089239) (← links)
- Intradermal delivery of plasmid VEGF(165) by electroporation promotes wound healing (Q39505195) (← links)
- Local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system (Q46041567) (← links)
- AHR, a novel acute hypoxia-response sequence, drives reporter gene expression under hypoxiain vitroandin vivo (Q50542441) (← links)
- Both CD133(+) cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells. (Q50581015) (← links)
- Uterine-Derived CD11b Cells Significantly Increase Vasculogenesis and Promote Myocardial Healing in Ischemic Cardiomyopathy. (Q52899317) (← links)
- Prevention of distal flap necrosis in a rat random skin flap model by gene electro transfer delivering VEGF(165) plasmid. (Q53349485) (← links)
- Cell therapy of critical limb ischemia-problems and prospects (Q92997279) (← links)